Reversal of GATA-6 downregulation promotes smooth muscle differentiation and inhibits intimal hyperplasia in balloon-injured rat carotid artery

Circulation Research

Volumn 84, Issue 6, 1999, Pages 647-654

  Mano, Toshiaki ^a   Luo, Zhengyu ^a   Malendowicz, Slawomir L ^b   Evans, Todd ^b   Walsh, Kenneth ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Adenovirus; Gene expression; Genes; Muscle, smooth; Restenosis

Indexed keywords

CELL NUCLEUS ANTIGEN; COMPLEMENTARY DNA; MITOGENIC AGENT; MYOSIN HEAVY CHAIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 6; UNCLASSIFIED DRUG; VIRUS VECTOR; ZINC FINGER PROTEIN;

ADENOVIRUS; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL INJURY; CAROTID ARTERY; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; GENE EXPRESSION; GENE TRANSFER; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; RESTENOSIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0033515612     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.6.647     Document Type: Article

References (41)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Dussaillant GR, Mintz GS, Richard AD, Kent KM, Salter LF, Popma JJ, Wong SC, Leon MB. Small stent size and intimai hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. J Am Coll Cardiol. 1995;26:720-724.
3. Dilley RJ, McGeachie JK, Prendergast FJ. A review of the histologic changes in vein-to-artery grafts, with particular reference to intimal hyperplasia. Arch Surg. 1988;123:691-696.
4. Braun-Dullaeus R, Mann M, Dzau V. Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation. 1998;98: 82-89.
5. Simon MC. Gotta have GATA. Nat Genet. 1995;11:9-11.
6. Grépin C, Nemer G, Nemer M. Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor. Development. 1997;124:2387-2395.
7. Grépin C, Robitaille L, Antakly T, Nemer M. Inhibition of transcription factor GATA-4 expression blocks in vitro cardiac muscle differentiation. Mol Cell Biol. 1995;15:4095-4102.
8. Durocher D, Charron F, Warren R, Schwartz R, Nemer M. The cardiac transcription factors Nkx2.5 and GATA-4 are mutual cofactors. EMBO J. 1997;16:5687-5696.
9. Durocher D, Nemer M. Combinatorial interactions regulating cardiac transcription. Dev Genet. 1998;22:250-262.
10. McGrew M, Bogdanova N, Hasegawa K, Hughes S, Kitsis R, Rosenthal N. Distinct gene expression patterns in skeletal and cardiac muscle are dependent on common regulatory sequences in the MLC1/3 Locus. Mol Cell Biol. 1996;16:4524-4534.
11. Jiang Y, Evans T. The Xenopus GATA-4/5/6 genes are associated with cardiac specification and can regulate cardiac-specific transcription during embryogenesis. Dev Biol. 1996;174:258-270.
12. Molkentin JD, Lin Q, Duncan SA, Olson EN. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 1997;11:1061-1072.
13. Kuo CT, Morrisey EE, Anandappa R, Sigrist K, Lu MM, Parmacek MS, Soudais C, Leiden JM. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev. 1997;11: 1048-1060.
14. Jiang Y, Tarzami S, Burch JB, Evans T. Common role for each of the cGATA-4/5/6 genes in the regulation of cardiac morphogenesis. Dev Genet. 1998;22:263-277.
15. Morrisey EE, Ip HS, Parmacek MS. GATA-6: a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm. Dev Biol. 1996;177:309-323.
16. Suzuki E, Evans T, Lowry J, Truong L, Bell DW, Testa JR, Walsh K. The human GATA-6 gene: structure, chromosomal location and regulation of expression by tissue-specific and mitogen-responsive signals. Genomics. 1996;38:283-290.
17. Fornace AJ, Jackman J, Hollander MC, Hoffman-Liebermann B, Liebermann DA. Genotoxic-stress-response genes and growth arrest genes: gadd, MyD, and other genes induced by treatments eliciting growth arrest. Ann N Y Acad Sci. 1992;663:139-153.
18. Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell. 1988;54:787-793.
19. 1 cell cycle arrest. J Biol Chem. 1998; 273:13713-13718.
20. Perlman H, Maillard L, Krasinski K, Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells following balloon injury. Circulation. 1997;95:981-987.
21. Wei GL, Krasinski K, Keamey M, Isner JM, Walsh K, Andrés V. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Circ Res. 1997;80:418-426.
22. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
23. Mader SL. Influence of animal age on the β-adrenergic system in cultured rat aortic and mesenteric artery smooth muscle cells J Gerontol. 1992; 47:B32-B36.
24. Graham FL, Prevec L. Adenovirus-based expression vectors and recombinant vaccines. Biotechnology. 1992;20:363-390.
25. Graham FL, van der Eb AJ. A new technique for assay of infectivity of human adenovirus 5 DNA. Virology. 1973;52:456-467.
26. CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev. 1997;11:1674-1689.
27. Ko L, Yamamoto M, Leonard M, George K, Ting P, Engel J. Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer. Mol Cell Biol. 1991;11:2778-2784.
28. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995;75:487-517.
29. Brinck U, Mirzaie M, Korabiowska M, Meyer T. Expression rate of vinculin isoforms in human aortocoronary saphenous vein grafts. Int J Cardiol. 1997;59:125-132.
30. Glukhova M, Kabakov A, Frid M, Ornatsky O, Belkin A, Mukhin D, Orekhov A, Koteliansky V, Smimov V. Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc Natl Acad Sci U S A. 1988;85:9542-9546.
31. Chamley-Campbell J, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev. 1979;59:1-61.
32. Campbell GR, Campbell JH. Phenotypic modulation of smooth muscle cells in primary culture. In: Campbell JH, Campbell GR, eds. Vascular Smooth Muscle in Culture. Boca Raton, Fla: CRC Press Inc; 1987: 139-155.
33. Aikawa M, Sivam PN, Kuro-o M, Kimura K, Nakahara K, Takewaki S, Ueda M, Yamaguchi H, Yazaki Y, Periasamy M, Nagai R. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res. 1993;73:1000-1012.
34. Chen YH, Chen YL, Lin SJ, Chou CY, Mar GY, Chang MS, Wang SP. Electron microscopic studies of phenotypic modulation of smooth muscle cells in coronary arteries of patients with unstable angina pectoris and postangioplasty restenosis. Circulation. 1997;95:1169-1175.
35. Walsh K, Perlman H. Molecular strategies to inhibit restenosis: modulation of the vascular myocyte phenotype. Semin Interv Cardiol. 1996;1: 173-179.
36. Gorski DH, Walsh K. Mitogen-responsive nuclear factors that mediate growth control signals in vascular myocytes. Cardiovasc Res. 1995;30: 585-592.
37. Weir L, Chen D, Pastore C, Isner JM, Walsh K. Expression of GAX, a growth-arrest homeobox gene, is rapidly down-regulated in the rat carotid artery during the proliferative response to balloon injury. J Biol Chem. 1995;270:5457-5461.
38. Chang MW, Barr E, Lu MM, Barton K, Leiden JM. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest. 1995;96:2260-2268.
39. Smith RC, Wills KN, Antelman D, Perlman H, Truong LN, Krasinski K, Walsh K. Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retinoblastoma protein inhibit myocyte proliferation and neointima formation. Circulation. 1997; 96:1899-1905.
40. Morishita R, Gibbons GH, Ellison KE, Nakajima M, von der Leynen H, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. Intimai hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest. 1994;93:1458-1464.
41. Chang MW, Barr E, Seltzer J, Jiang Y, Nabel GJ, Nabel EG, Parmacek MS, Leiden JM. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science. 1995;267:518-522.